Clearance of the intracellular high level of the Tau protein directed by an artificial synthetic hydrolase

被引:9
作者
Chu, Ting-Ting [1 ]
Li, Qian-Qian [1 ]
Qiu, Tian [1 ]
Sun, Zhan-Yi [1 ]
Hu, Zhi-Wen [1 ]
Chen, Yong-Xiang [1 ]
Zhao, Yu-Fen [1 ]
Li, Yan-Mei [1 ,2 ]
机构
[1] Tsinghua Univ, Dept Chem, Minist Educ, Key Lab Bioorgan Phosphorus Chem & Chem Biol, Beijing 100084, Peoples R China
[2] Beijing Inst Brain Disorders, Beijing 100069, Peoples R China
基金
中国国家自然科学基金;
关键词
PAIRED HELICAL FILAMENTS; ALZHEIMERS-DISEASE; INDUCED DEFECTS; MOUSE MODELS; DEGRADATION; COPPER; REDUCTION; STRATEGIES; MEMORY;
D O I
10.1039/c4mb00508b
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Promoting clearance of intracellular excessive tau is a potential therapeutic strategy for treating Alzheimer's disease. In this work, we designed and synthesized a cyclen-hybrid artificial 'hydrolase' I1-Cu(II) to cleave tau in vitro. Furthermore, a cell-permeable 'hydrolase' I2-Cu(II), derived from I1-Cu(II), was also synthesized to cleave intracellular tau proteins.
引用
收藏
页码:3081 / 3085
页数:5
相关论文
共 31 条
  • [1] Tau-mediated neurodegeneration in Alzheimer's disease and related disorders
    Ballatore, Carlo
    Lee, Virginia M. -Y.
    Trojanowski, John Q.
    [J]. NATURE REVIEWS NEUROSCIENCE, 2007, 8 (09) : 663 - 672
  • [2] Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments
    Barghorn, S
    Mandelkow, E
    [J]. BIOCHEMISTRY, 2002, 41 (50) : 14885 - 14896
  • [3] Structural analysis of intrinsically disordered proteins by small-angle X-ray scattering
    Bernado, Pau
    Svergun, Dmitri I.
    [J]. MOLECULAR BIOSYSTEMS, 2012, 8 (01) : 151 - 167
  • [4] Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7
  • [5] Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies
    Brunden, Kurt R.
    Trojanowski, John Q.
    Lee, Virginia M. -Y.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (10) : 783 - 793
  • [6] High throughput screening for small molecule inhibitors of heparin-induced tau fibril formation
    Crowe, Alex
    Ballatore, Carlo
    Hyde, Edward
    Trojanowski, John Q.
    Lee, Virginia M. -Y.
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 358 (01) : 1 - 6
  • [7] Copper and Oxidative Stress in the Pathogenesis of Alzheimer's Disease
    Eskici, Goezde
    Axelsen, Paul H.
    [J]. BIOCHEMISTRY, 2012, 51 (32) : 6289 - 6311
  • [8] Tau-targeted treatment strategies in Alzheimer's disease
    Goetz, Juergen
    Ittner, Arne
    Ittner, Lars M.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2012, 165 (05) : 1246 - 1259
  • [9] Cyclen-hybrid compound captures copper to protect INS-1 cells from islet amyloid polypeptide cytotoxicity by inhibiting and lysing effects
    Hu, Jia
    Yu, Ye-Ping
    Cui, Wei
    Fang, Chuan-Lin
    Wu, Wei-Hui
    Zhao, Yu-Fen
    Li, Yan-Mei
    [J]. CHEMICAL COMMUNICATIONS, 2010, 46 (42) : 8023 - 8025
  • [10] Alzheimer Mechanisms and Therapeutic Strategies
    Huang, Yadong
    Mucke, Lennart
    [J]. CELL, 2012, 148 (06) : 1204 - 1222